Titlebook: Gastrointestinal and Hepatic Manifestations of Rheumatic Diseases; Hiromasa Ohira,Kiyoshi Migita Book 2019 Springer Nature Singapore Pte L

誘導

Liver Involvement in Rheumatic Diseases,tions between rheumatic diseases and the liver are complex, because rheumatic diseases target multiple systemic organs, including the liver. In addition, both treatment with immunosuppressants and secondary viral infections can cause liver dysfunction. Although liver dysfunction in rheumatic disease

lanugo

Primary Biliary Cholangitis Is Associated with CREST Syndrome,intrahepatic bile ducts that may eventually lead to liver failure. Patients with PBC occasionally suffer complications from other autoimmune diseases. When PBC is associated with calcinosis, Raynaud’s phenomenon, esophageal dysmotility, sclerodactyly, and telangiectasias (CREST) symptoms, it has bee

拉開這車床

Bone-Scan

人充滿活力

Portal Hypertension in Rheumatic Diseases,mechanism leading to portal hypertension often involves idiopathic portal hypertension, pulmonary hypertension, and liver cirrhosis. In systemic lupus erythematosus, mixed connective tissue disease, and systemic sclerosis, in particular, portal hypertension is often reported..Esophagogastric varices

negotiable

Gastrointestinal Manifestations of Systemic Lupus Erythematosus,to the anus. Lupus enteritis is one of the most common GI manifestations and defined as either vasculitis or inflammation of the small bowel, with supportive image and/or biopsy findings. Vasculitis also causes lupus colitis. Protein-losing enteropathy is one of the GI manifestations that shows hypo

aerial

Rheumatoid Arthritis and Gastrointestinal Tract Lesions (NSAID Ulcers, Amyloidosis),myloidosis, both of which are gastrointestinal tract lesions. NSAID ulcers associated with RA are not as common as they once were. There are three reasons for this. First, the role of NSAIDs in rheumatoid arthritis treatment has changed. Second, NSAIDs less damaging to the intestines have become ava

HALO

Yourself

Morsel